Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

Overview of attention for article published in Current opinion in ophthalmology, May 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 1 policy source

patent: 11 patents

Readers on

mendeley: 84 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Anti-Vascular Endothelial Growth Factor Drugs for the Treatment of Retinal Conditions: A Review of Safety

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 28 Feb 2017

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.